IDF23-0223 Targeting miR-122 and miR-4756 mitigates atherogenic events by upregulating Sestrin2 under high glucose condition

Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Tags: Cardiovascular Disease Source Type: research